These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38922179)

  • 1. Engineering Short Antimicrobial Peptides to Specifically Target
    Liu Z; Wang Y; Zhang C; Yang Y; Zhang J
    ACS Infect Dis; 2024 Jun; ():. PubMed ID: 38922179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide.
    Nakagaki H; Sekine S; Terao Y; Toe M; Tanaka M; Ito HO; Kawabata S; Shizukuishi S; Fujihashi K; Kataoka K
    Infect Immun; 2010 Mar; 78(3):1185-92. PubMed ID: 20008529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rice peptide with amino acid substitution inhibits biofilm formation by Porphyromonas gingivalis and Fusobacterium nucleatum.
    Matsugishi A; Aoki-Nonaka Y; Yokoji-Takeuchi M; Yamada-Hara M; Mikami Y; Hayatsu M; Terao Y; Domon H; Taniguchi M; Takahashi N; Yamazaki K; Tabeta K
    Arch Oral Biol; 2021 Jan; 121():104956. PubMed ID: 33157493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum.
    Liu PF; Huang IF; Shu CW; Huang CM
    Curr Mol Med; 2013 Sep; 13(8):1358-67. PubMed ID: 23865430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of a 40-kDa outer membrane protein, FomA, of Fusobacterium periodonticum and comparison with Fusobacterium nucleatum.
    Bolstad AI; Høgh BT; Jensen HB
    Oral Microbiol Immunol; 1995 Oct; 10(5):257-64. PubMed ID: 8596666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased proliferation and decreased membrane permeability as defense mechanisms of Fusobacterium nucleatum against human neutrophilic peptide-1.
    Keskin M; Könönen E; Söderling E; Isik G; Firatli E; Uitto VJ; Gürsoy UK
    Anaerobe; 2014 Dec; 30():35-40. PubMed ID: 25132418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soybean peptide inhibits the biofilm of periodontopathic bacteria via bactericidal activity.
    Lwin HY; Aoki-Nonaka Y; Matsugishi A; Takahashi N; Hiyoshi T; Tabeta K
    Arch Oral Biol; 2022 Oct; 142():105497. PubMed ID: 35849907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging strategies for combating
    Liu H; Yu Y; Dong A; Elsabahy M; Yang YW; Gao H
    Exploration (Beijing); 2024 Feb; 4(1):20230092. PubMed ID: 38854496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusobacterium nucleatum Metabolically Integrates Commensals and Pathogens in Oral Biofilms.
    Sakanaka A; Kuboniwa M; Shimma S; Alghamdi SA; Mayumi S; Lamont RJ; Fukusaki E; Amano A
    mSystems; 2022 Aug; 7(4):e0017022. PubMed ID: 35852319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria.
    Sun M; Zhou Z; Dong J; Zhang J; Xia Y; Shu R
    Microb Pathog; 2016 Oct; 99():196-203. PubMed ID: 27565090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiofilm activity of ultra-small gold nanoclusters against Fusobacterium nucleatum in dental plaque biofilms.
    Zhang Y; Chen R; Wang Y; Wang P; Pu J; Xu X; Chen F; Jiang L; Jiang Q; Yan F
    J Nanobiotechnology; 2022 Nov; 20(1):470. PubMed ID: 36329432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed oral biofilms are controlled by the interspecies interactions of Fusobacterium nucleatum.
    Valadbeigi H; Khoshnood S; Negahdari B; Maleki A; Mohammadinejat M; Haddadi MH
    Oral Dis; 2023 Nov; ():. PubMed ID: 38009960
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Gu X; Song LJ; Li LX; Liu T; Zhang MM; Li Z; Wang P; Li M; Zuo XL
    Front Microbiol; 2020; 11():1281. PubMed ID: 32733392
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of
    Rutherford JT; Avad K; Dureja C; Norseeda K; Gc B; Wu C; Sun D; Hevener KE; Hurdle JG
    ACS Infect Dis; 2024 May; 10(5):1612-1623. PubMed ID: 38597503
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of a bacteriocin-producing
    Lawrence GW; McCarthy N; Walsh CJ; Kunyoshi TM; Lawton EM; O'Connor PM; Begley M; Cotter PD; Guinane CM
    Gut Microbes; 2022; 14(1):2100203. PubMed ID: 35877697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-free quantitative proteomic analysis of the oral bacteria Fusobacterium nucleatum and Porphyromonas gingivalis to identify protein features relevant in biofilm formation.
    Ali Mohammed MM; Pettersen VK; Nerland AH; Wiker HG; Bakken V
    Anaerobe; 2021 Dec; 72():102449. PubMed ID: 34543761
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Thurnheer T; Karygianni L; Flury M; Belibasakis GN
    Front Microbiol; 2019; 10():1716. PubMed ID: 31417514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of Metallostasis in the Anaerobic Human Pathogen
    Van Zuylen EM; Ferguson SA; Hughes A; Rennison D; Brimble MA; Cook GM
    ACS Infect Dis; 2021 Aug; 7(8):2285-2298. PubMed ID: 34259502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
    Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
    World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological and functional adaptations of Fusobacterium nucleatum exposed to human neutrophil Peptide-1.
    Musrati AA; Fteita D; Paranko J; Könönen E; Gürsoy UK
    Anaerobe; 2016 Jun; 39():31-8. PubMed ID: 26923748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.